GB1482132A - Interferon formulation - Google Patents

Interferon formulation

Info

Publication number
GB1482132A
GB1482132A GB33136/74A GB3313674A GB1482132A GB 1482132 A GB1482132 A GB 1482132A GB 33136/74 A GB33136/74 A GB 33136/74A GB 3313674 A GB3313674 A GB 3313674A GB 1482132 A GB1482132 A GB 1482132A
Authority
GB
United Kingdom
Prior art keywords
july
interferon
covalent bonds
support
interferon formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB33136/74A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Santé et de la Recherche Médicale
Original Assignee
Institut National de la Santé et de la Recherche Médicale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Santé et de la Recherche Médicale filed Critical Institut National de la Santé et de la Recherche Médicale
Publication of GB1482132A publication Critical patent/GB1482132A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
GB33136/74A 1973-07-27 1974-07-26 Interferon formulation Expired GB1482132A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7327538A FR2244543B1 (cg-RX-API-DMAC10.html) 1973-07-27 1973-07-27

Publications (1)

Publication Number Publication Date
GB1482132A true GB1482132A (en) 1977-08-03

Family

ID=9123222

Family Applications (1)

Application Number Title Priority Date Filing Date
GB33136/74A Expired GB1482132A (en) 1973-07-27 1974-07-26 Interferon formulation

Country Status (7)

Country Link
US (1) US4041152A (cg-RX-API-DMAC10.html)
JP (1) JPS50116618A (cg-RX-API-DMAC10.html)
CH (1) CH618345A5 (cg-RX-API-DMAC10.html)
DE (1) DE2436172A1 (cg-RX-API-DMAC10.html)
FR (1) FR2244543B1 (cg-RX-API-DMAC10.html)
GB (1) GB1482132A (cg-RX-API-DMAC10.html)
SE (1) SE7409732L (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2351665A1 (fr) * 1976-05-21 1977-12-16 Elf Aquitaine Procede de purification de preparations possedant notamment une activite interferon, preparations purifiees ainsi obtenues et leur application en tant que medicament
IN150740B (cg-RX-API-DMAC10.html) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4503035B1 (en) * 1978-11-24 1996-03-19 Hoffmann La Roche Protein purification process and product
SE445013B (sv) * 1979-06-21 1986-05-26 Landstingens Inkopscentral Medel for att forebygga eller behandla infektioner hos menniskor och djur
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
JPS5651995A (en) * 1979-10-05 1981-05-09 Green Cross Corp:The Preparation of interferon
JPS5823847B2 (ja) * 1981-02-06 1983-05-18 株式会社 林原生物化学研究所 抗ヒト蛋白質抗体の製造方法
EP0090837A1 (en) * 1981-10-08 1983-10-12 BERG, Kurt Frimann Method and composition for treating a patient suffering from interferonsusceptible disorder
HU184972B (en) * 1981-12-01 1984-11-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing human gamma interferone
EP0150067A3 (en) * 1984-01-23 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon
US4745180A (en) * 1986-06-27 1988-05-17 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using heparin fragments
JPH04503607A (ja) * 1989-02-24 1992-07-02 イムノセラピューティックス・インコーポレイテッド 固定化サイトカイン類
WO1997007820A1 (fr) * 1995-08-30 1997-03-06 Toray Industries, Inc. Remede destine aux maladies cardiaques
AU7684000A (en) * 1999-10-12 2001-04-23 Santen Pharmaceutical Co. Ltd. Interferon complex and medicinal use thereof
US20090081162A1 (en) * 2004-08-31 2009-03-26 Michael Tovey Method for downregulating an immune reaction
MX2007013725A (es) 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.

Also Published As

Publication number Publication date
FR2244543B1 (cg-RX-API-DMAC10.html) 1977-07-01
SE7409732L (cg-RX-API-DMAC10.html) 1975-01-28
DE2436172A1 (de) 1975-02-13
US4041152A (en) 1977-08-09
CH618345A5 (cg-RX-API-DMAC10.html) 1980-07-31
JPS50116618A (cg-RX-API-DMAC10.html) 1975-09-12
FR2244543A1 (cg-RX-API-DMAC10.html) 1975-04-18

Similar Documents

Publication Publication Date Title
AU450827B2 (en) Process for the preparation of oxidation products of ethylene polymers
NL190415C (nl) Reactieprodukten en esters van polyolen met tenminste 3 hydroxylgroepen en melkzuur, depotmatrixmateriaal en parenteraal farmaceutisch depot preparaat.
EP0427588A3 (en) System for the administration of sterile liquids, especially pharmaceutical, nutritive or energetic
AU6665074A (en) Carbanilides and process for the preparation thereof
CA996812A (en) Process for the continuous preparation of yoghurt and other fermented milk products
CA1026043A (en) High molecular weight polyimide polymers and process for the preparation of polyimide polymers
CA1029728A (en) Pyrimidine-thionothiolphosphoric acid esters, process for their preparation and their use as insecticides or acaricides
CA1010010A (en) Supporting apparatus for intravenous containers or the like
FR2224164A1 (en) Polysaccharide drug complexes - having longer lasting activity than the parent drug
CA974224A (en) Acid stable molecular sieve products
NL171270C (nl) Werkwijze voor de bereiding van 1,2,3,4,6,7,12,12a-octahydropyrazinoŸ2',1':6,1Ÿ pyridoŸ3,4-bŸindolen en werkwijze voor de bereiding van preparaten die ze bevatten.
AU5448786A (en) Polyprenyl compounds
NL7412300A (nl) Werkwijze voor de bereiding van een proteine bevattend melkprodukt.
AU476979B2 (en) 4'-alkoxyalkyleneoxy-5-benzylpyrimidines, their preparation and pharmaceutical compositions thereof
NL7413788A (nl) Werkwijze voor de bereiding van biologisch actieve benzoxazolen, werkwijze voor de be- reiding van een gevormd geneesmiddel en een dergelijk geneesmiddel.
ZA744750B (en) 16-methyl-pregna-1,4,9 (11)-triene-3,20-diones as medicaments- new processes for the preparation of these products, and pharmaceutical compositions
NL7410647A (nl) Werkwijze ter bereiding van een geneesmiddel met anti-trombosewerking en/of diagnosticum voor trombine in bloed, zo gevormd geneesmiddel, zo gevormd diagnosticum en werkwijze ter berei- ding van de daartoe geschikte actieve verbin- dingen.
AU473292B2 (en) 6-methylprednisolone derivatives, process for the preparation thereof and pharmaceutical compositions containing same
NL7507422A (nl) Werkwijze voor de bereiding van een geneesmiddel met bloeddrukverlagende werking, een dergelijk ge- neesmiddel en een werkwijze voor de bereiding van de actieve verbindingen.
AR243540A1 (es) Procedimiento quimico para la depolimerizacion controlada de polianiones naturales y productos asi obtenidos, excluidos sus usos farmaceuticos.
CA1003418A (en) 1,3-BIS(.beta.-ETHYLHEXYL)-5-AMINO-5-METHYLHEXAHYDROPYRIMIDINE-PYRIDINE-3-CARBOXYLATE AND PROCESS FOR THE PREPARATION THEREOF
NL7513376A (nl) Werkwijze voor de bereiding van pyridinen, werk- wijze voor de bereiding van een geneesmiddel met bloeddrukverlagende werking en geneesmiddel met een dergelijke werking.
AU472259B2 (en) Combined product hanger and label support
AU450130B2 (en) Improvements relating to support systems for the seated human body
NL7514062A (nl) Werkwijze voor de bereiding van gehalogeneerde ben- zoguanaminen, werkwijze voor de bereiding van een geneesmiddel met anti-ulcuswerking en een dergelijk geneesmiddel.

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee